Inflammatory cardiovascular involvement due to COVID-19, defined by research hub

Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19)

This study looks at new ways to protect the heart after inflammation caused by COVID-19. Researchers are testing two existing medicines to see if they can help improve heart function and reduce long-term problems. It aims to find better treatments for your heart post-COVID.